Prostate cancer patients often delay chemotherapy, fearing its side effects, but the new research could upend established practices. [Category: Chemotherapy, Johnson & Johnson|JNJ|NYSE, Sanofi SA|SNY|NYSE, American Society of Clinical Oncology, Breast Cancer, Medivation Inc|MDVN|NASDAQ, Prostate Cancer] http://rss.nytimes.com/c/34625/f/640346/s/3b0b2db6/sc/14/l/0L0Snytimes0N0C20A140C0A60C0A20Chealth0Cearly0Echemotherapy0Eextends0Elives0Eof0Emen0Ewith0Eprostate0Ecancer0Estudy0Efinds0Bhtml0Dpartner0Frss0Gemc0Frss/story01.htm
Read More
No comments:
Post a Comment